Bristol-Myers Squibb | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.74B 111M 2025-03
ALKERMES USD 0 285.82M 2024-12
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.89B 154M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 23.99B 622M 2025-01
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Sanofi 11.79B 712M 2024-12
United Therapeutics USD 0 0 2025-03
Zoetis USD 5.22B 1.35B 2024-12



Bristol-Myers Squibb Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.